Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case

• 作 者: Cheng-Ming Li Zhi-Chao Liu You
• 机 构: SchoolofMedicineandLifeSciences,DepartmentofRadiationOncology,DepartmentofOncology,SchoolofMedicine
• 出 处: 世界胃肠病学杂志：英文版
• 发表日期: 2017年41期
• 基金项目: Supported by The National Natural Science Foundation of China,No.81402299,the Project of Postdoctoral Innovation of Shandong Province,No.201501010,the Project of Postdoctoral Science Foundation of Chi

Chemotherapy has limited efficacy in the treatment of advanced and metastatic pancreatic cancer(PC), and has serious side effects. The development of novel effective agents, especially targeted therapy, is essential for patients with PC. We present a 58-y